Its 2030-hour half-life means that a single administration produces a prolonged elevation of free IGF1R-binding peptide, making it well-suited for in vivo anabolic or metabolic studies in which continuous infusion is impractical
Standard injectable dosing ranges from 0.25 mg to 0.5 mg daily for most applications
Disclosure of interest: Xinjie Gao: nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P158 - ESOC25-1869 ACCURACY OF AUTOMATED HEMORRHAGE SUBTYPE DETECTION IN SUSPECTED INTRACEREBRAL HEMORRHAGE James Garrard 1,2 , Artem Kaliaev 3 , Asim Mian 3 , Chad Farris 3 , Pau Bellot 1 , Olivier Joly 1 , Zoe Woodhead 1 , James Briggs 1,4 , Davide Carone *1 , George Harston 1,2 , Mohamad Abdalkader 3 1 Brainomix, OXFORD, United Kingdom, 2 Oxford University Hospitals, OXFORD, United Kingdom, 3 Boston Medical Centre, Boston, United States, 4 Royal Berkshire Hospital, Reading, United Kingdom Background and Aims: Early identification of patients with intracerebral hemorrhage (ICH) is thought to be critical to improve outcomes through earlier implementation of evidence-based care-bundles
LPS, lipopolysaccharide
Ismaeil FM, Ahmed SEE, Jabereldar AA, El-Naim AM, Ahmed EEBM
